To determine whether DX2 acts as a competitive inhibitor of AIMP2, suppressing AIMP2-induced PARP-1 activation and neuronal cell death, we transfected neuroblastoma cells with DX2-plasmid vectors and -siRNA, and subsequently measured the binding of AIMP2 to PARP-1. The gene discussed is PARP1; the disease is neuroblastoma.